home-hospital Hospital-level care for acutely ill adults in the comfort of their own home.
Learn more
home-hospital
Hospital-level care for acutely ill adults in the comfort of their own home. Learn more

When you see each
patient a million
times a day...

...You see the
bigger picture.

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition designed to help clinicians predict and prevent deterioration before it happens.

When you see each patient a million times a day... You see the bigger picture.

animation_heads_circle_01
animation_heads_circle_02
animation_heads_circle_03
animation_heads_circle_04
animation_heads_circle_05
wave_m

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition that helps predict and prevent deterioration before it happens.

wave_trans

We're powering personally predictive care...
so everyone can see better outcomes.

What if patients suffering from heart failure, COPD, chronic pain, or cancer could spend less time in hospitals and more time feeling confident and cared for at home? What if networks, clinicians, and payers could turn fewer readmissions into a higher level of care for all? And what if drug companies could more dramatically demonstrate, in real-time, the physiological impact and value of pharmacotherapy candidates?

At Biofourmis, we use patient physiology data and advanced analytics to turn those "what-ifs" into "ah-has" for some of the world's most respected healthcare providers and pharmaceutical companies—collaborators like Novartis, Chugai, Brigham and Women's Hospital, and Mayo Clinic that use our clinically validated, predictive platform to more precisely manage, intervene, and treat chronic patients in a way that's proactive and liberating. That's the power of personally predictive care.

Get To Know Us

The Biovitals® platform shows you more than patient data.
It can help show you patient futures.

ProductLineup

Our Biovitals® platform collects and interprets vast amounts of population metadata and compares it to real-time patient physiological signals to provide a clearer picture of chronic patients and their disease trajectory—a real-time picture designed to help clinicians predict and prevent serious medical events. Its actionable insights powered by machine learning, deep neural networks, and a clinical-grade Everion® wearable.

See How Biovitals® Works

Predict and prevent costly medical events with a modular, user-friendly platform.

Biovitals® delivers actionable information by bringing disease, data, machine-learning, and clinical-grade hardware together in one customizable ecosystem. Learn how we can tailor Biovitals® to improve real-world outcomes for the unique needs of health systems, payers and pharmaceutical companies.

Hospitals Icon Created with Sketch.
Payors Icon Created with Sketch.
Pharma Icon Created with Sketch.

Health Systems

  • Improve clinical outcomes by reducing readmissions and ED visits
  • Improve workflow efficiencies, care team capacity and ongoing communication with patients
  • Realize more rapid personalized treatment and communication for efficient management of patients with complex chronic conditions

Payers

  • Reduce overall healthcare expenditures while improving clinical outcomes
  • Improve quality of life for members with complex chronic conditions
  • Deliver members more targeted and timely intervention and engagement support based on their personalized needs

Pharmaceutical Companies

  • Augment drug efficacy and outcomes using drug + digital intervention
  • Accelerate development time frames by accelerating clinical trials using digital tools
  • Increase patient share, adherence, and engagement
  • Increase reimbursements and/or value-based payments
Hospitals Icon Created with Sketch.

Health Systems

Payors Icon Created with Sketch.

Payers

Pharma Icon Created with Sketch.

Pharmaceutical Companies

Clinical evidence and science guides everything we do

Around the world and across multiple collaborations and studies, our Biovitals® Platform is helping clinical teams see patients like never before.

Collaborators and Investors

We're proud to collaborate with some of the world's most respected healthcare organizations, research hospitals, and biopharma companies. Together, we're improving patient outcomes, advancing clinical research, reducing healthcare costs, and accelerating drug research and development.

COLLABORATORS

norvatis
chugai
mundipharma
astrazeneca
mayo-clinic
mass-general
bwh
singhealth
cersi
nsw
hku
univHongkong

INVESTORS

softbank
sequioa
massmutual
edbi
openspace
spesnet
SGinnovate

Biofourmis in the news.

Let's get you up to speed.

news-entry
Health IT execs offer thoughts on the big issues of 2021

I've seen it said before that year-ahead predictions are like weather reports: Everyone reads them, but almost no one looks back later to see whether they were accurate. Still, since when has that stopped anyone from indulging in this pastime as the calendar turns from December to January?

January 31, 2021

news-entry
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models built at a single institution, even when there is copious data to train with. As an added bonus, researchers can collaborate on AI model creation without sharing confidential patient information. Federated learning is also beneficial for building AI models for areas where data is scarce, such as for pediatrics and rare diseases.

December 30, 2020

news-entry
Scaling Up the Home Hospital Program at Brigham and Women’s

In November, when the Centers for Medicare & Medicaid Services expanded its acute hospital at home program, it granted immediate waivers to six health systems with extensive experience providing acute hospital care at home, including Brigham and Women’s Hospital in Boston. In a recent interview, David Levine, M.D., M.P.H., who leads Brigham’s program, discussed its plans to scale up and the overall impact of the CMS waiver program.

December 21, 2020

news-entry Fierce Healthcare
Health executives take out their crystal balls: Here are their predictions for 2021

"In 2021, we'll see a continued move from 'pay-per-pill' to pay-for-value when it comes to drug therapy. This transition will be accelerated by technology such as clinical-grade wearables, remote patient monitoring, patient-facing apps, and AI-powered analytics.

December 21, 2020

Biofourmis News

Let's connect.

We're helping some of the most respected names in healthcare deliver measurably better outcomes. Let us show you what personally predictive care can do for your organization.

Contact Us